Search results
Results from the WOW.Com Content Network
The mission of Technology Transfer at National Institutes of Health (NIH) is to facilitate partnerships with a wide array of stakeholders, and effectively manage the inventions conceived by scientists working at the NIH and the Centers for Disease Control and Prevention (CDC). In doing so, NIH Technology Transfer supports the larger NIH mission ...
Generative Pre-trained Transformer 2 (GPT-2) is a large language model by OpenAI and the second in their foundational series of GPT models. GPT-2 was pre-trained on a dataset of 8 million web pages. [2] It was partially released in February 2019, followed by full release of the 1.5-billion-parameter model on November 5, 2019. [3] [4] [5]
Robert Ray Redfield Jr. [1] [2] was born on July 10, 1951. His parents, Robert Ray Redfield (1923–1956, from Ogden) and Betty, née Gasvoda, [1] were both scientists at the National Institutes of Health, [3] where his father was a surgeon and cellular physiologist at the National Heart Institute; [1] Redfield's career in medical research was influenced by this background. [3]
All NIH Institutes and Centers are involved with OSC in the design, implementation, and evaluation of Common Fund programs. [15] commonfund.nih.gov: Office of Technology Transfer: OTT manages the wide range of NIH and FDA intramural inventions as mandated by the Federal Technology Transfer Act and related legislation.
The mid-20th century was a time of expansion for both NIH and the PHS environmental health programs. In 1948, NIH's name was changed to the plural National Institutes of Health, and by the end of 1950 six new institutes had been created within it. [22]
NCIRD supports and supervises state and local agencies working on immunization activities and commercial contracting for vaccine supply and distribution. NCIRD supports a national framework for surveillance of diseases for which immunizing agents are increasingly becoming available from commercial pharmaceutical companies, and assists health departments in developing vaccine information ...
GPT-4o ("o" for "omni") is a multilingual, multimodal generative pre-trained transformer developed by OpenAI and released in May 2024. [1] GPT-4o is free, but ChatGPT Plus subscribers have higher usage limits. [2] It can process and generate text, images and audio. [3]
ChatGPT is a generative artificial intelligence chatbot developed by OpenAI and launched in 2022. It is currently based on the GPT-4o large language model (LLM). ChatGPT can generate human-like conversational responses and enables users to refine and steer a conversation towards a desired length, format, style, level of detail, and language. [2]